Tauro α‐muricholate is as effective as tauro β‐muricholate and tauroursodeoxycholate in preventing taurochenodeoxycholate‐induced liver damage in the rat
Kenichi Kitani, Setsuko Kanai, Yuko Sato, Minoru Ohta – 1 April 1994 – Male Wistar rats were infused intravenously with taurochenodeoxycholate (0.4 μmol/min/100 gm) alone (group A) or with one of the three bile salts (tauroursodeoxycholate [group B], tauro β‐muricholate [group C] or tauro α‐muricholate [group D]) at a rate of 0.2 μmol/min/100/gm for 1 hr. One‐hour bile flow and bile salt excretion rates were significantly lower in group A than in the other three coinfused (B, C, D) groups.